SequelSEC

INVO Fertility, Inc. IVF

Surgical & Medical Instruments & Apparatus · CIK 0001417926 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$2.18M
Fiscal year ended 2026-06-30
Operating income
-$1.29M
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

INVO Fertility, Inc. (IVF) reported revenue of $2.18M and net income of $888.74K for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from INVO Fertility, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

INVO Fertility, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Revenue$2.18M$2.02M$1.58M$1.76M$1.86M$1.64M$1.69M$1.43M$1.84M$1.58M
Cost of revenue$60.15K$5.15KUnavailableUnavailable$3.06K$3.98K$1.02M$988.46K$861.65K$862.10K
Gross profit$2.12M$2.01MUnavailableUnavailable$1.86M$1.63MUnavailableUnavailableUnavailable$714.18K
Operating income-$1.29M-$1.59M-$1.41M-$1.64M-$2.99M-$1.20M-$1.97M-$1.30M-$1.85M-$1.51M
Net income$888.74K-$5.54M$1.10M-$3.40M-$3.62M-$17.40M-$3.79M-$1.63M-$2.25M-$1.60M
Research & developmentUnavailableUnavailableUnavailableUnavailableUnavailable$265.66K$0$0$0$4.88K
Weighted-average diluted sharesshares 2.59Mshares 1.64MUnavailableshares 3.45MUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Pretax income$944.89KUnavailable$1.86M-$2.64M-$1.54M-$17.40M-$2.16M-$1.60M-$2.25M-$1.59M
Income tax expense$56.15K$0UnavailableUnavailableUnavailable$0$109.11K$29.26K$0$1.84K
Diluted EPS$0.35$-3.38Unavailable$-39.40$-364.23$-3,473.93Unavailable$-15.11$-22.39$-7.55
Selling, general & administrative$1.91M$2.18M$1.81M$2.13M$2.19M$1.56M$2.46M$1.51M$2.65M$1.44M
General & administrativeUnavailableUnavailableUnavailableUnavailableUnavailable$1.31MUnavailableUnavailableUnavailable$272.08K
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailable$12.97KUnavailableUnavailableUnavailable$7.61K

Balance

INVO Fertility, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Cash & equivalentsUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Total assets$25.83M$24.66M$20.22M$18.83M$19.32M$31.74M$46.08M$17.02M$17.75M$17.34M
Current assets$4.60M$5.73M$2.76M$1.14M$1.40M$1.57M$1.26M$1.96M$2.40M$1.72M
Total liabilities$9.34M$9.63M$13.00M$13.01M$16.19M$24.43M$26.04M$17.04M$16.39M$17.33M
Current liabilities$6.52M$6.36M$10.33M$9.13M$12.14M$18.72M$17.87M$8.66M$7.95M$8.80M
Total equity incl. NCI$16.49M$15.02M$7.22M$5.82M-$7.15M-$27.20M$12.58M-$23.32K$1.36M$10.16K
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailable$10.12M$34.35M$7.46MUnavailableUnavailableUnavailable
Inventory$251.29K$224.56K$225.25K$191.76K$212.61K$216.46K$219.76K$241.54K$250.07K$266.45K
Accounts receivable$257.73K$248.39K$217.26K$274.20K$242.26K$173.61K$113.11K$257.05K$257.21K$176.89K
Goodwill$9.25M$6.52M$5.88M$5.88M$5.88M$8.89M$5.88M$5.88M$5.88M$5.88M
Long-term debt$513.39K$660.16K$744.72K$951.67K$1.04MUnavailable$1.13MUnavailableUnavailableUnavailable
Accounts payableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Cash flow

INVO Fertility, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Operating cash flow-$1.10M-$1.92M$25.21K-$1.78M-$1.72M-$3.55M-$617.38K-$640.81K-$1.46M-$260.56K
Capital expendituresUnavailableUnavailable$11.82K$8.06K$8.88K$14.65K$78.87K$0$55.13K$49.70K
Investing cash flow-$2.22K-$210.00K-$2.71M-$8.06K-$15.45K-$14.65K$393.13K$0-$5.13K-$24.11K
Financing cash flow-$67.85K$4.95M$4.40M$1.59M$1.44M$3.66M$494.05K$169.46K$1.93M$527.37K
Net change in cash-$1.17M$2.83M$1.72M-$193.29K-$291.23K$99.01K$269.80K-$471.34K$467.81K$242.70K
Stock-based compensationUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortization$145.57K$142.70K$136.42K$136.74K$169.74K$234.46K$231.81K$230.50K$230.34K$226.96K

Derived

INVO Fertility, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Free cash flowUnavailableUnavailable$13.38K-$1.78M-$1.73M-$3.56M-$696.25K-$640.81K-$1.51M-$310.26K
Gross margin97.2%99.7%UnavailableUnavailable99.8%99.8%UnavailableUnavailableUnavailable45.3%
Operating margin-59.3%-78.9%-89.2%-93.1%-160.4%-73.3%-116.6%-90.7%-100.9%-95.7%
FCF marginUnavailableUnavailable0.8%-101.6%-92.6%-217.5%-41.3%-44.7%-82.3%-19.7%
SBC / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Current ratio0.71x0.90x0.27xUnavailableUnavailable0.08x0.07x0.23x0.30xUnavailable
Revenue YoY growth16.7%23.1%-6.1%22.6%1.5%3.9%22.0%47.0%481.4%352.9%
Net margin40.9%Unavailable69.2%Unavailable-194.2%Unavailable-224.6%-113.8%UnavailableUnavailable
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable0.0%0.0%0.0%0.3%
CapEx / revenueUnavailableUnavailable0.7%0.5%0.5%0.9%4.7%0.0%3.0%3.2%
Long-term debt / equity0.03xUnavailable0.10xUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rate5.9%UnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open IVF in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-14View SEC filing
10-Q · Filed 2026-06-22View SEC filing
10-K · Filed 2026-06-02View SEC filing
10-Q · Filed 2025-11-17View SEC filing
10-Q · Filed 2025-08-14View SEC filing
10-Q · Filed 2025-05-20View SEC filing

Companies in the same industry

Reconciliation checks needing review

4 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

gross profit bridgeinconsistent2024-12-31

Withheld: gross profit could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2024-09-30

Withheld: gross profit could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2024-06-30

Withheld: gross profit could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2023-03-31

Withheld: cost revenue could not be reconciled with the rest of this filer’s statement.